Lisa Zaba MD PHD

medderm, supportive onco-dermatology, Rheumderm, immunotherapy, Merkel cell carcinoma. Faculty @ Stanford. Tweets posted are my own, not medical advice.

[AADmember @AADmember]

In a @JAADjournals review, the authors examined the 5-year survival rate of early-stage #Merkelcellcarcinoma patients with lymphovascular invasion compared to patients without lymphovascular invasion. https://t.co/jtgANgDDbx #DermWorldWeekly

[Lisa Zaba MD PHD @LisaZabaMD]

In this article, everything you need to know about getting the COVID-19 vaccine if you have psoriasis https://t.co/uN5VsaPSxQ #dermtwitter

[Lisa Zaba MD PHD @LisaZabaMD]

Comprehensive review on how to treat Merkel cell carcinoma from Stanford and UW experience. https://t.co/Gl5t3tE4cu

[Lisa Zaba MD PHD @LisaZabaMD]

@JosephMerolaMD @bwhdermatology @DrScottElman This is wonderful Joe! Congrats on this!

[Lisa Zaba MD PHD @LisaZabaMD]

Case report showing successful management of HIV- Kaposi Sarcoma with immunotherapy while managing concomitant psoriasis and bullous pemphigoid. #medtwitter #dermtwitter https://t.co/vwatZPicRX via @AJMC_Journal

[Lisa Zaba MD PHD @LisaZabaMD]

My first tweet #dermtwitter